๐ฐ Van Cutsem News
Page 4 - Van Cutsem News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Van Cutsem. Real-time updates on events, politics, business and more.
October 29, 2023
By November, clerical opinion was starting to shift in favour of marriage between Charles and Camilla, says author Tina Brown. But it was a social snub that sealed the deal...
October 17, 2023
A gamekeeper has admitted having an offensive weapon on a Norfolk estate belonging to a close friend of Prince William.
September 21, 2023
BeiGene Announces Positive Regulatory Updates in Europe and the U.S. After Recently Regaining Global Rights for TEVIMBRA®Sep 19, 2023 6:15 AMEuropean Commission approves TEVIMBRA for previously treated advanced or metastatic esophageal squamous cell carcinoma (ESCC)U.S. FDA accepts Biologics License Ap...
September 19, 2023
European Commission approves TEVIMBRA for previously treated advanced or metastatic esophageal squamous cell carcinoma U.S. FDA accepts Biologics License Application in first-line advanced ESCC ...
August 31, 2023
Designations for Daiichi Sankyo and AstraZenecas ENHERTU include patients with HER2 expressing metastatic solid tumors and HER2 positive metastatic colorectal cancer ENHERTU has now been granted...
July 9, 2023
Here FEMAIL reveals how friends of thePrince of Wales and Prince Harry have been left stuck in the middle amidst the brothers royal rift - and who appears to have taken sides.
June 6, 2023
Prince Constantine Alexios of Greece and Poppy Delevingne appear to have headed on holiday with one another, and they looked so sweet on a photo shared by the royal
June 5, 2023
AstraZeneca and Daiichi Sankyo’s ENHERTU showed an objective response rate of 37.1% in the overall population of the DESTINY-PanTumor02 Phase II trial ENHERTU is the first therapy to show... | June 5, 2023
May 25, 2023
Royals pulling faces at weddings: See when Mike Tindall, Sarah Ferguson, the Queen, Princess Charlene and more lost control of their reactions and it was caught on camera.
May 17, 2023
Triplet therapy consisting of encorafenib, cetuximab, and binimetinib demonstrated activity and manageable safety as first-line treatment for patients with BRAF V600Eโmutated metastatic colorectal cancer.